Profound Medical Corp. (PROF) NASDAQ
7.18
+0.04(+0.56%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
7.18
+0.04(+0.56%)
Currency In USD
| Market Cap | 237.93M |
| Enterprise Value | 162.59M |
| P/E Ratio | -7.99 |
| PEG Ratio | 0.59 |
| Price/Sales Ratio | 12.87 |
| Price/Book Ratio | 4.3 |
| Enterprise/Revenue | 10.28 |
| Enterprise/EBITDA | -5.62 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -1.93 |
| Operating Margin | -1.9 |
| Return On Assets | -0.44 |
| Return On Equity | -0.73 |
| Revenue | 16.1M |
| Revenue/Share | 0.64 |
| Gross Profit | 11.39M |
| EBITDA | -40.69M |
| Net Income | -42.57M |
| Diluted EPS | 1.41 |
| Total Cash | 50.46M |
| Total Cash/Share | 1.93 |
| Total Debt | 7.49M |
| Total Debt/Equity | 0.13 |
| Current Ratio | 6.56 |
| Book Value Per Share | 2.28 |
| 52-Week Change | 68.15 |
| 52-Week High | 8.95 |
| 52-Week Low | 3.76 |
| Moving Average 50 Days | 6.36 |
| Moving Average 200 Days | 6.24 |
| Average Volume | 195,621 |
| Shares Outstanding | 30.26M |
| % Held by Institutions | 53.34 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | October 16, 2019 |